| [1] | LI Mingying, ZHANG Xiaoxia, SUN Xiaoli, ZHAO Yan, HE Miao, LI Yanling, DUAN Wei, YANG Ou. 
														
															Effect of Sugammadex on Recovery of Patients after Laparoscopic Total Pelvic Floor Reconstruction
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 896-901. | 
																																																																																
													| [2] | ZHAO Jie, GAO Minge, CHANG Hong, FAN Huixia. 
														
															Pathogen Distribution, Drug Resistance and Drug Use in Neonates with Necrotizing Enterocolitis Complicated with Sepsis
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 909-913. | 
																																																																																
													| [3] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. 
														
															Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. | 
																																																																																
													| [4] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. 
														
															Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. | 
																																																																																
													| [5] | KE Xiuqin, HAI Xuewu. 
														
															433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. | 
																																																																																
													| [6] | LIANG Jie. 
														
															172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. | 
																																																																																
													| [7] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. 
														
															Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. | 
																																																																																
													| [8] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. 
														
															Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. | 
																																																																																
													| [9] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. 
														
															One Case of Acute Withdrawal Syndrome Caused by Naloxone
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. | 
																																																																																
													| [10] | YANG Xin, YANG Baochun, YANG Yang, SHAO Huan. 
														
															One Case of Multiple Endocrine Adverse Effect Caused by Sintilimab
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 947-949. | 
																																																																																
													| [11] | WANG Chunting, CHEN Yafei. 
														
															Considerations for Revision of Safety Information in the Post-Marketing Instructions of Chemical Drugs
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 776-779. | 
																																																																																
													| [12] | ZHU Huijuan, REN Jingtian. 
														
															Safety Risks of Human Rabies Immunoglobulin
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 786-789. | 
																																																																																
													| [13] | CHEN Yaozhe, ZHAN Yunli, SONG Xingdong, ZHU Manyu, OU Xuemei, LI Chuyun. 
														
															48 Cases of Hematological Adverse Reactions Associated with Piperacillin Sodium and Tazobactam Sodium
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 794-798. | 
																																																																																
													| [14] | CAO Kai, QIAN Peipei, GAO Xin, YANG Futian, ZHAO Liang, XU Bingxin, ZHANG Xianjun. 
														
															Mining of Risk Signals Adverse Events Related to Drug-Induced Salivary Gland Calculus Based on FAERS Database
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 799-804. | 
																																																																																
													| [15] | LIN Lu, ZHAO Anzhi, CHEN Jinhui, LI Zhongwen, HUANG Guohua, ZHONG Shilong. 
														
															One Case of Delayed Hypersensitivity Reactions Caused by Cefotaxime Sodium and Sulbactam Sodium for Injection
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 809-811. |